860538 | C8 Galactosyl(ß) Ceramide (d18:1/8:0)
D-galactosyl-ß-1,1' N-octanoyl-D-erythro-sphingosine
Info
C8 Galactosyl(ß) Ceramide (d18:1/8:0)
D-galactosyl-ß-1,1' N-octanoyl-D-erythro-sphingosine
Data
No
No
C32H61NO8
C 65.38%, H 10.46%, N 2.38%, O 21.77%
>99%
1 Years
-20°C
CAS Number
41613-16-5
CAS Registry Number is a Registered Trademark of the American Chemical Society
CAS Registry Number is a Registered Trademark of the American Chemical Society
587.829
587.44
C8 ß-D-galactosyl ceramide
N-(octanoyl)-1-ß-galactosyl-sphing-4-enine
N-(octanoyl)-1-ß-galactosyl-sphing-4-enine
References
Hou B, Zhao Y, He P, Xu C, Ma P, Lam SM, Li B, Gil V, Shui G, Qiang G, Liew CW, Du G. Targeted lipidomics and transcriptomics profiling reveal the heterogeneity of visceral and subcutaneous white adipose tissue. Life Sci. 2020 Jan 29;245:117352. doi: 10.1016/j.lfs.2020.117352. Epub ahead of print. PMID: 32006527.
PubMed ID: 32006527Li M, Tong X, Lv P, Feng B, Yang L, Wu Z, Cui X, Bai Y, Huang Y, Liu H. A not-stop-flow online normal-/reversed-phase two-dimensional liquid chromatography-quadrupole time-of-flight mass spectrometry method for comprehensive lipid profiling of human plasma from atherosclerosis patients. J Chromatogr A. 2014 Dec 12;1372C:110-119. doi: 10.1016/j.chroma.2014.10.094. Epub 2014 Nov 3. PMID: 25465009.
PubMed ID: 25465009
Certificates of Analysis
- Certificate of Analysis (Lot No. 860538P-25MG-A-019 and 5988PJA019)
- Certificate of Analysis (Lot No. 860538P-5MG-A-019 and 5988PHA019)
- Certificate of Analysis (Lot No. 860538P-25MG-B-019 and 5988PJB019)
- Certificate of Analysis (Lot No. 860538P-5MG-B-019 and 5988PHB019)
- Certificate of Analysis (Lot No. 860538P-5MG-C-019 and 5988PHC019)
- Certificate of Analysis (Lot No. 860538P-5MG-D-019 and 5988PHD019)
- Certificate of Analysis (Lot No. 860538P-5MG-E-019 and 5988PHE019)